472 related articles for article (PubMed ID: 27732819)
1. A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
; ; Davey RT; Dodd L; Proschan MA; Neaton J; Neuhaus Nordwall J; Koopmeiners JS; Beigel J; Tierney J; Lane HC; Fauci AS; Massaquoi MBF; Sahr F; Malvy D
N Engl J Med; 2016 Oct; 375(15):1448-1456. PubMed ID: 27732819
[TBL] [Abstract][Full Text] [Related]
2. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
Sissoko D; Laouenan C; Folkesson E; M'Lebing AB; Beavogui AH; Baize S; Camara AM; Maes P; Shepherd S; Danel C; Carazo S; Conde MN; Gala JL; Colin G; Savini H; Bore JA; Le Marcis F; Koundouno FR; Petitjean F; Lamah MC; Diederich S; Tounkara A; Poelart G; Berbain E; Dindart JM; Duraffour S; Lefevre A; Leno T; Peyrouset O; Irenge L; Bangoura N; Palich R; Hinzmann J; Kraus A; Barry TS; Berette S; Bongono A; Camara MS; Chanfreau Munoz V; Doumbouya L; Souley Harouna ; Kighoma PM; Koundouno FR; Réné Lolamou ; Loua CM; Massala V; Moumouni K; Provost C; Samake N; Sekou C; Soumah A; Arnould I; Komano MS; Gustin L; Berutto C; Camara D; Camara FS; Colpaert J; Delamou L; Jansson L; Kourouma E; Loua M; Malme K; Manfrin E; Maomou A; Milinouno A; Ombelet S; Sidiboun AY; Verreckt I; Yombouno P; Bocquin A; Carbonnelle C; Carmoi T; Frange P; Mely S; Nguyen VK; Pannetier D; Taburet AM; Treluyer JM; Kolie J; Moh R; Gonzalez MC; Kuisma E; Liedigk B; Ngabo D; Rudolf M; Thom R; Kerber R; Gabriel M; Di Caro A; Wölfel R; Badir J; Bentahir M; Deccache Y; Dumont C; Durant JF; El Bakkouri K; Gasasira Uwamahoro M; Smits B; Toufik N; Van Cauwenberghe S; Ezzedine K; D'Ortenzio E; Pizarro L; Etienne A; Guedj J; Fizet A; Barte de Sainte Fare E; Murgue B; Tran-Minh T; Rapp C; Piguet P; Poncin M; Draguez B; Allaford Duverger T; Barbe S; Baret G; Defourny I; Carroll M; Raoul H; Augier A; Eholie SP; Yazdanpanah Y; Levy-Marchal C; Antierrens A; Van Herp M; Günther S; de Lamballerie X; Keïta S; Mentre F; Anglaret X; Malvy D;
PLoS Med; 2016 Mar; 13(3):e1001967. PubMed ID: 26930627
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S; Dodd LE; Davey RT; Tshiani Mbaya O; Proschan M; Mukadi D; Lusakibanza Manzo M; Nzolo D; Tshomba Oloma A; Ibanda A; Ali R; Coulibaly S; Levine AC; Grais R; Diaz J; Lane HC; Muyembe-Tamfum JJ; ; Sivahera B; Camara M; Kojan R; Walker R; Dighero-Kemp B; Cao H; Mukumbayi P; Mbala-Kingebeni P; Ahuka S; Albert S; Bonnett T; Crozier I; Duvenhage M; Proffitt C; Teitelbaum M; Moench T; Aboulhab J; Barrett K; Cahill K; Cone K; Eckes R; Hensley L; Herpin B; Higgs E; Ledgerwood J; Pierson J; Smolskis M; Sow Y; Tierney J; Sivapalasingam S; Holman W; Gettinger N; Vallée D; Nordwall J;
N Engl J Med; 2019 Dec; 381(24):2293-2303. PubMed ID: 31774950
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.
Bai CQ; Mu JS; Kargbo D; Song YB; Niu WK; Nie WM; Kanu A; Liu WW; Wang YP; Dafae F; Yan T; Hu Y; Deng YQ; Lu HJ; Yang F; Zhang XG; Sun Y; Cao YX; Su HX; Sun Y; Liu WS; Wang CY; Qian J; Liu L; Wang H; Tong YG; Liu ZY; Chen YS; Wang HQ; Kargbo B; Gao GF; Jiang JF
Clin Infect Dis; 2016 Nov; 63(10):1288-1294. PubMed ID: 27553371
[TBL] [Abstract][Full Text] [Related]
5. Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
Lee JS; Adhikari NKJ; Kwon HY; Teo K; Siemieniuk R; Lamontagne F; Chan A; Mishra S; Murthy S; Kiiza P; Hajek J; Bah EI; Lamah MC; Kao R; Fowler RA
BMC Infect Dis; 2019 May; 19(1):376. PubMed ID: 31046707
[TBL] [Abstract][Full Text] [Related]
6. Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study.
Kerber R; Lorenz E; Duraffour S; Sissoko D; Rudolf M; Jaeger A; Cisse SD; Camara AM; Miranda O; Castro CM; Akoi Bore J; Raymond Koundouno F; Repits J; Afrough B; Becker-Ziaja B; Hinzmann J; Mertens M; Vitoriano I; Hugh Logue C; Böttcher JP; Pallasch E; Sachse A; Bah A; Cabeza-Cabrerizo M; Nitzsche K; Kuisma E; Michel J; Holm T; Zekeng EG; Cowley LA; Garcia-Dorival I; Hetzelt N; Baum JHJ; Portmann J; Carter L; Yenamaberhan RL; Camino A; Enkirch T; Singethan K; Meisel S; Mazzarelli A; Kosgei A; Kafetzopoulou L; Rickett NY; Patrono LV; Ghebreghiorghis L; Arnold U; Colin G; Juchet S; Marchal CL; Kolie JS; Beavogui AH; Wurr S; Bockholt S; Krumkamp R; May J; Stoecker K; Fleischmann E; Ippolito G; Carroll MW; Koivogui L; Magassouba N; Keita S; Gurry C; Drury P; Diallo B; Formenty P; Wölfel R; Di Caro A; Gabriel M; Anglaret X; Malvy D; Günther S
J Infect Dis; 2019 Jun; 220(2):195-202. PubMed ID: 30788508
[TBL] [Abstract][Full Text] [Related]
7. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
Tshiani Mbaya O; Mukumbayi P; Mulangu S
Front Immunol; 2021; 12():721328. PubMed ID: 34526994
[TBL] [Abstract][Full Text] [Related]
8. Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola.
Caluwaerts S
Reprod Health; 2017 Dec; 14(Suppl 3):157. PubMed ID: 29297408
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and Outcomes of Pediatric Patients With Ebola Virus Disease Admitted to Treatment Units in Liberia and Sierra Leone: A Retrospective Cohort Study.
Smit MA; Michelow IC; Glavis-Bloom J; Wolfman V; Levine AC
Clin Infect Dis; 2017 Feb; 64(3):243-249. PubMed ID: 28011610
[TBL] [Abstract][Full Text] [Related]
10. Enhanced case management can be delivered for patients with EVD in Africa: Experience from a UK military Ebola treatment centre in Sierra Leone.
Dickson SJ; Clay KA; Adam M; Ardley C; Bailey MS; Burns DS; Cox AT; Craig DG; Espina M; Ewington I; Fitchett G; Grindrod J; Hinsley DE; Horne S; Hutley E; Johnston AM; Kao RLC; Lamb LE; Lewis S; Marion D; Moore AJ; Nicholson-Roberts TC; Phillips A; Praught J; Rees PS; Schoonbaert I; Trinick T; Wilson DR; Simpson AJ; Wang D; O'Shea MK; Fletcher TE
J Infect; 2018 Apr; 76(4):383-392. PubMed ID: 29248587
[TBL] [Abstract][Full Text] [Related]
11. Clinical Management of Ebola Virus Disease in the United States and Europe.
Uyeki TM; Mehta AK; Davey RT; Liddell AM; Wolf T; Vetter P; Schmiedel S; Grünewald T; Jacobs M; Arribas JR; Evans L; Hewlett AL; Brantsaeter AB; Ippolito G; Rapp C; Hoepelman AI; Gutman J;
N Engl J Med; 2016 Feb; 374(7):636-46. PubMed ID: 26886522
[TBL] [Abstract][Full Text] [Related]
12. Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques.
Guedj J; Piorkowski G; Jacquot F; Madelain V; Nguyen THT; Rodallec A; Gunther S; Carbonnelle C; Mentré F; Raoul H; de Lamballerie X
PLoS Med; 2018 Mar; 15(3):e1002535. PubMed ID: 29584730
[TBL] [Abstract][Full Text] [Related]
13. Treatment of ebola virus disease.
Kilgore PE; Grabenstein JD; Salim AM; Rybak M
Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
[TBL] [Abstract][Full Text] [Related]
14. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.
Qiu X; Wong G; Audet J; Bello A; Fernando L; Alimonti JB; Fausther-Bovendo H; Wei H; Aviles J; Hiatt E; Johnson A; Morton J; Swope K; Bohorov O; Bohorova N; Goodman C; Kim D; Pauly MH; Velasco J; Pettitt J; Olinger GG; Whaley K; Xu B; Strong JE; Zeitlin L; Kobinger GP
Nature; 2014 Oct; 514(7520):47-53. PubMed ID: 25171469
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report.
Schibler M; Vetter P; Cherpillod P; Petty TJ; Cordey S; Vieille G; Yerly S; Siegrist CA; Samii K; Dayer JA; Docquier M; Zdobnov EM; Simpson AJH; Rees PSC; Sarria FB; Gasche Y; Chappuis F; Iten A; Pittet D; Pugin J; Kaiser L
Lancet Infect Dis; 2015 Sep; 15(9):1034-1040. PubMed ID: 26201298
[TBL] [Abstract][Full Text] [Related]
16. Ebola Virus Disease and Pregnancy: A Retrospective Cohort Study of Patients Managed at 5 Ebola Treatment Units in West Africa.
Henwood PC; Bebell LM; Roshania R; Wolfman V; Mallow M; Kalyanpur A; Levine AC
Clin Infect Dis; 2017 Jul; 65(2):292-299. PubMed ID: 28379374
[TBL] [Abstract][Full Text] [Related]
17. Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone.
Ji YJ; Duan XZ; Gao XD; Li L; Li C; Ji D; Li WG; Wang LF; Meng YH; Yang X; Ling BF; Song XA; Gu ML; Jiang T; Koroma SM; Bangalie J; Duan HJ
Infect Dis Poverty; 2016 Nov; 5(1):101. PubMed ID: 27806732
[TBL] [Abstract][Full Text] [Related]
18. Effects of therapies for Ebola virus disease: a systematic review and network meta-analysis.
Gao Y; Zhao Y; Guyatt G; Fowler R; Kojan R; Ge L; Tian J; ; Hao Q
Lancet Microbe; 2022 Sep; 3(9):e683-e692. PubMed ID: 35803293
[TBL] [Abstract][Full Text] [Related]
19. Ebola-specific therapeutic antibodies from lab to clinic: The example of ZMapp.
Wong G; Bienes KM; Xiii A; Fausther-Bovendo H; Kobinger GP
Antiviral Res; 2024 Jun; 226():105873. PubMed ID: 38580170
[TBL] [Abstract][Full Text] [Related]
20. Tobacco against Ebola virus disease.
Budzianowski J
Przegl Lek; 2015; 72(10):567-71. PubMed ID: 26946569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
